Machine Learning-Guided Training for Elite Athletes (MLGT) (MLGT)
A Machine Learning-Guided Training Approach to Reduce Injuries and Enhance Performance in Elite Athletes: A Prospective Cohort Evaluation
Plaintext The purpose of this study is to evaluate whether a personalized training protocol driven by machine learning can successfully reduce time-loss sports injuries and enhance athletic performance in elite athletes.
During a 9-month competitive sports season, a group of elite athletes was divided into two training
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study evaluated the efficacy of an adaptive, machine learning-driven training protocol compared to traditional athletic preparation over a full 9-month competitive sports season. The primary objective was to determine if a dynamic, technology-led approach to training load management could minimize time-loss injuries while concurrently optimizing athletic performance markers.
Participants were elite athletes randomly allocated into two parallel groups:
- The Experimental Group, which underwent training regimens dynamically adjusted using a machine learning algorithm that analyzed individual biomechanical data and historical workload parameters to optimize training volume and intensity.
- The Control Group, which followed standard, predetermined high-performance athletic training protocols typical for competitive season preparation.
Throughout the 9-month intervention period, daily tracking was maintained by technical and coaching staff. Data collection focused on the incidence, severity, and duration of all time-loss sports injuries. Concurrently, sport-specific performance parameters were periodically assessed to evaluate physical conditioning and competitive readiness. Statistical analyses were subsequently conducted to compare cumulative injury rates, total days lost to injury, and net performance adaptations between the two cohorts.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Shewa
-
Debre Berhan, Shewa, Etiopía, 445
- Dr. Arefayne
-
Debre Berhan, Shewa, Etiopía, 445
- M Dessye
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Must be a competitive, elite-level or sub-elite track and field athlete specializing in short-to-mid distance running events.
- Aged between 18 and 35 years old.
- Actively participating in structured athletic training programs for at least 2 years prior to enrollment.
- Free from any acute musculoskeletal injuries or medical conditions that prevent full participation in high-intensity training protocols.
- Capable and willing to provide written informed consent to participate in the study.
Exclusion Criteria: 1. Current or recent (within the past 3 months) major lower-limb injury or surgery that restricts maximal sprint or aerobic performance.
2. Concurrent use of performance-enhancing drugs or medications that influence metabolic or cardiovascular responses.
3. Inability to maintain consistent participation in the designated training protocols due to scheduling conflicts or travel.
4. Any underlying cardiovascular, respiratory, or systemic condition that creates a health risk during exhaustive exercise testing.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Control Cohort
Elite adolescent sprinters who followed standard, predetermined high-performance athletic training protocols typical for competitive season preparation.
This group received structured training volume and intensity matching standard athletic coaching guidelines, without any machine learning interventions or adaptive workload adjustments.
|
A personalized, data-driven training intervention where athletic workloads are dynamically adjusted based on predictive modeling.
The protocol continuously tracks individual physiological markers, biomechanical data, and workload history to optimize training volume and intensity.
This adaptive approach aims to maximize performance gains while minimizing the risk of overtraining and injury during the competitive season.
|
|
Experimental: Algorithmic Cohort
Elite adolescent sprinters who received a personalized training protocol dynamically optimized by a machine learning algorithm.
The framework evaluated individual biomechanical variables, morning heart rate variability (HRV), sleep quality, and physiological fatigue metrics to adjust training volume and intensity.
|
A personalized, data-driven training intervention where athletic workloads are dynamically adjusted based on predictive modeling.
The protocol continuously tracks individual physiological markers, biomechanical data, and workload history to optimize training volume and intensity.
This adaptive approach aims to maximize performance gains while minimizing the risk of overtraining and injury during the competitive season.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes in Sprint Performance Time
Periodo de tiempo: 12 weeks
|
Sprint performance will be assessed using electronic timing gates to record running times over a specific distance from a stationary start.
Lower times indicate improved sprint performance.
Measurements will be taken at baseline and at the conclusion of the training intervention period to evaluate the impact of the workload protocols.
|
12 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Dr. Arefayne M Dessye, PhD, Debre Berhan Univeristy
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- DBU-SS-2023-008
- IRB#DBU-SS-2023-008 (Identificador de registro: ClinicalTrials.gov)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .